Grafts of human pluripotent ESC-derived cardiomyocytes for myocardial injury

TECHNIQUES CATEGORY: Drug platforms

TECHNOLOGY: Cell therapy

Grafts of cardiomyocytes derived from human pluripotent ESCs

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE